408: Whistleblower takes on health insurance and FDA commissioner candidates

Employer-based health insurance is failing as soaring costs outpace wage growth, creating an affordability crisis for both workers and businesses. High healthcare prices, driven by hospitals, drug companies, and insurers, force employers to pay unsustainable premiums, often leading them to drop coverage or shift costs to employees through high deductibles. GLP-1 medications further strain these budgets, forcing difficult trade-offs. Small businesses, in particular, face extreme pressure, sometimes opting to eliminate insurance entirely or provide funds for employees to seek coverage on Affordable Care Act exchanges, which are themselves impacted by expiring subsidies. Chris Deacon, a former health benefits overseer, highlights that employers often remain complicit by failing to challenge the status quo or demand contract transparency. Addressing this systemic issue requires moving beyond superficial cost-cutting to tackle the underlying unit prices of medical services and pharmaceutical products.